BioLargo, Inc. · OTC:BLGO

BioLargo — Investor Presentation (March 2018)

27 slides from BioLargo's investor presentation, Mar 8, 2018

  1. Slide 1: We Make Life Better

    We Make Life Better ) BioLargo A Sustainable Technology Incubator Providing Solutions for Large Environmental Challenges ‘di Stock Symbol: BLGO Westminster, CA Safe Harbor Statement The statements contained herein, which are not historical, are forward-looking statements that are subject to risks an

  2. Slide 2: Two Active, Two in Development

    Two Active, Two in Development - All Large Opportunities cr WNNM) Odor-No-More Tw CupriDyne’ ‘CLEAN - \G}BioLargo aeeaee see ereeeeeees CLYRA Medical Technologies Inc > AOS 6 BioLargo We Moke Life Better Proprietary BioLargo Technology selling into industrial odor control markets Environmental Engin

  3. Slide 3: Platform Technology Incubator

    Platform Technology Incubator ( BioLargo * 17 patents issued, 5 pending * Approximately $13 Million invested in product development ¢ We incubate platforms to market- readiness, then: v Licensure ¥ Joint Venture v IP Sale ec. v Direct-to-Market High Tech Innovation Awards an OCTANe Signature Event 2

  4. Slide 4: The Iodine Cycle - Nature Shows Us the Way!

    The Iodine Cycle - Nature Shows Us the Way! lodine Used Reactive DSR 00 (Aeccconta lodine Species & vd IY Nutrient oO. of, Ars ye = \=@ All-Natural lodine Cycle

  5. Slide 5: Collaborations, Grants, Awards

    Collaborations, Grants, Awards (BioLargo (>55 government grants) fo Moke Ute Botte Agri-Food AUBERT: N mA « si UCLA SASKATCHEWAN ts) t N ty ERSI 1 , CWWASS ACEI ye: ACEPU National Water Research Institute & EREF Albert NAC IRAP LA innovates ‘te poe EPC2R TEER eS = Futures” Cy ‘) SUSTAIN ORANGE COUNT

  6. Slide 6: Growth Strategy

    Growth Strategy “We Make Life Better” 2—~w CypriDyt Dyne’ @c LYRA (Caciean 4 Medical Technologies Inc | | INVENT | \ y ( BioLargo PARTNER |

  7. Slide 7: Commercially Active Subsidiaries

    Commercially Active Subsidiaries ( BioLargo i Were Cuptipye (QNM) Odor-No-More™ upri nt ated Ps / Oo} BioLargo Engineering , Science & Technologies

  8. Slide 8: First Major Commercial Success - CupriDyne Clean

    BioLargo We Make life Better First Major Commercial Success - ( CupriDyne Clean Industrial Odor & VOC Control © “Finally a product that actually works” * Market entry requires customer trust - landfill operator * Word is out; sales expanding * 3 National Purchasing Agreements with top solid waste co

  9. Slide 9: Market Opportunity — Landfills

    Market Opportunity — Landfills ( BioLargo We Make Life Better Site Type ce eee 3% market 5% market 10% market 20% market sites(US revenue share share share share Market)! per site per year? Landfills 1,900 $120,000 $6,840,000 $11,400,000 $22,800,000 $45,600,000 ¢ Approximately 275 landfills operated

  10. Slide 10: Market Opportunity - Transfer Stations

    BioLargo We Make Life Better Market Opportunity é - Transfer Stations d Site Type Oe eee ee 3% market 5% market 10% market 20% market sites (US revenue share share share share Market)! per site per year? Transfer 7,600 $48,000 $10,944,000 $18,240,000 $36,480,000 $72,960,000 Stations ¢ Approximately

  11. Slide 11: Market Opportunity — Wastewater Treatment Plants

    BioLargo We Make Life Better Market Opportunity é — Wastewater Treatment Plants d Site Type oe wate) |) 3% market 5% market 10% market 20% market sites (US revenue share share share share Market) _ per site 2 per year? Wastewater 15,000 $48,000 $21,600,000 $36,000,000 $72,000,000 $144,000,000 Treatm

  12. Slide 12: CupriDyne Clean Industrial Odor Control

    CupriDyne Clean Industrial Odor Control ()8!9Lr90 ¢ Effective against hydrogen sulfide, ammonia, mercaptans, VOCs, and sulfur dioxide and fatty acids * Non-toxic, non-sensitizing, fragrance free, Generally Recognized As Safe (GRAS), confirmed non-pesticide * Cost savings of 25% - 50% for customers *

  13. Slide 13: CupriDyne Clean in Action!

    CupriDyne Clean in Action! (b BioLargo

  14. Slide 14: CupriDyne Clean in Action!

    CupriDyne Clean in Action! ( BioLargo eu

  15. Slide 15: BioLargo Engineering

    BioLargo Engineering - Biol. World-Class Talent b omen gO ¢ Veterans from Shaw and CB&I with 200+ years field experience First 10 clients under contract (small) ¢ Internal and external work oO BioLargo Engineering, Science & Technologies * Targeting positive cash flow mid 2018 * Synergy with ONM (mu

  16. Slide 16: Track Record

    Track Record (s BioLargo We Make Life Bett ¢ Substantial DOD & DOE Work ¢ Project leadership in Katrina Recovery & Haiti rebuilding efforts * Developed technology solution to eliminate Anthrax from notable US landmark buildings ¢ Developed ammonium bicarbonate technology for fertilizer * Developed t

  17. Slide 17: In-Development Technologies

    In-Development Technologies f CLYRA Medical Technologies Inc Ya 6) BioLargo’ ’ Water “AOS CANADA NT sevoncesonston system le Moke Life Better 7

  18. Slide 18: Advanced Wound Care - Disrupter in $18 Billion Global Market?

    Advanced Wound Care - Disrupter in $18 Billion Global Market? ¢ Awaiting FDA 510(k) clearance (first product filed Fall 2017) ( BioLargo ¢ Second product to file soon * ‘The gold standard - without the collateral damage’ + Infection Control A “* Disinfection for Chronic Wounds = LY R Medical Technol

  19. Slide 19: Clyra Advantage - Best-in-class Comparison

    Clyra Advantage - Best-in-class Comparison ¢ 3ioLargo Silver dressings vs. Clyra dressings Al ute Cost Bacterial Resistance Delivered in Dosage Delivery Method Staining Toxic Fungicidal Nutrient Release Duration Copper Release Effective Against Biofilm Silver Dre: Expensive Controversial Yes Impregn

  20. Slide 20: Clyra Execution Strategy

    Clyra Execution Strategy 6 BioLargo Invent product Capitaliz and Licenseinto +> Patent |, apita d e Clyra (staged) ——— Spin-Off Clyra FDAA } bo Clinical Work to from BioLargo to sees Expand Marketing Maximize Shareholder Value tu We are here - application in process

  21. Slide 21: Advanced Oxidation System (AOS)

    Advanced Oxidation System (AOS) ( BioLargo LOW COST SOLUTION (OPEX AND CAPEX) LEAST POWER CONSUMPTION ELIMINATES RECALCITRANT CONTAMINANTS 6) BioLargo Water

  22. Slide 22: AOS - Proven Super Oxide Generation

    AOS - Proven Super Oxide Generation (4 8ioLargo We Make Life Better AOS destroys difficult organic contaminants faster' than: ¢ UV * Ozone + hydrogen peroxide + AOS produces powerful iodine oxides * Proven at world-famous Canadian Light Source * Traditional iodine used in disinfection is in the form

  23. Slide 23: MWD ICP-Sponsored Case Studies

    MWD ICP-Sponsored Case Studies ( BioLargo We Mok Two Case Studies sponsored by the Metropolitan Water District of Southern California’s Innovative Conservation Program (ICP). > Official report on these studies can be found at our blog (www.biolargo.com/blog) Poultry processing wastewater case Munici

  24. Slide 24: High Value Water Markets

    High Value Water Markets (b BioLargo We Make Life Bet First targeting: * Oil & Gas (Oil Sands) ¢ Agricultural water * F&B Wastewater + Tertiary municipal treatment But there are countless applications for AOS’ high performance and low cost value prop. in the future: * Data centers * Home * Municipal

  25. Slide 25: AOS Development History

    AOS Development History (b BioLargo

  26. Slide 26: Financial status

    Financial status ( BioLargo We Make Life Bet StockSymbol:BLGO Current Approximate Price: $0.30 Shares Outstanding = 105 Million Market Cap: $30M * Two active commercial operations - sales increasing, 3"¢ online in 2018 - 4 target late 2018/2019 + Lincoln Park Capital committed to purchase up to $10

  27. Slide 27: The BioLargo Family of Companies

    Stock Symbol: BLGO Dennis Calvert President & CEO BioLargo, Inc. 14921 Chestnut St. Westminster, CA 92683 (949) 643-9540 x2 dc@biolargo.com www.biolargo.com The BioLargo Family of Companies S BioLargo We Make Life Better BioLargo, Inc. is a sustainable science, technology & full-service environmenta

BioLargo — Investor Presentation (March 2018) on 6ix